JATT II Acquisition Corp. (JATT NYSE) stock market data APIs
$12.3223
0.05(0.4%)
as of September 11, 2026
Try our APIs with
free plan!
JATT II Acquisition Corp. Financial Data Overview
Price chart is built with
Anychart
JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey.
Prev. Close
12.3223
Open
12.3749
High
12.376
Low
12.0728
52 wk Range
9.99-14.5
Market Cap
95 550 K
Shares Outstanding
7 800 K
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get JATT II Acquisition Corp. data using free add-ons & libraries
Get JATT II Acquisition Corp. Fundamental Data
JATT II Acquisition Corp. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get JATT II Acquisition Corp. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
JATT II Acquisition Corp. News
New
JATT III Acquisition prices $60M IPO at $10 per share
[IPO Initial Public Offering on Financial Stock Market Chart 3D render] gonin * JATT III Acquisition (JATT [https://seekingalpha.com/symbol/JATT]) priced [https://seekingalpha.com/pr/20630049-jatt-...
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
New Jersey-based biotech, Talawar Therapeutics and JATT II Acquisition have joined forces through a definitive business combination agreement – creating a new biotech that's aiming to disrupt the cr...
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, t...
JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited
LONDON, March 16, 2023--(BUSINESS WIRE)--JATT Acquisition Corp (NYSE: JATT) ("JATT"), a publicly traded special purpose acquisition company, today announced that its shareholders voted to approve its ...
Get JATT II Acquisition Corp. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
